2001
DOI: 10.1016/s1360-1385(01)01922-7
|View full text |Cite
|
Sign up to set email alerts
|

Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants

Abstract: The use of plants for medicinal purposes dates back thousands of years but genetic engineering of plants to produce desired biopharmaceuticals is much more recent. As the demand for biopharmaceuticals is expected to increase, it would be wise to ensure that they will be available in significantly larger amounts, on a cost-effective basis. Currently, the cost of biopharmaceuticals limits their availability. Plant-derived biopharmaceuticals are cheap to produce and store, easy to scale up for mass production, an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
423
0
4

Year Published

2002
2002
2011
2011

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 665 publications
(435 citation statements)
references
References 54 publications
8
423
0
4
Order By: Relevance
“…Although pharmaceutical proteins have been synthesized from plant nuclear transgenes, expression levels (particularly of human proteins) are generally disappointingly low [38]. Chloroplasts, with their highly polyploid genomes offer an ideal compartment for overproduction of foreign proteins.…”
Section: Engineering the Chloroplast Genome To Overproduce Biopharmacmentioning
confidence: 99%
“…Although pharmaceutical proteins have been synthesized from plant nuclear transgenes, expression levels (particularly of human proteins) are generally disappointingly low [38]. Chloroplasts, with their highly polyploid genomes offer an ideal compartment for overproduction of foreign proteins.…”
Section: Engineering the Chloroplast Genome To Overproduce Biopharmacmentioning
confidence: 99%
“…Animal-, plant-, and insect cell cultures have become significant tools in the production of proteins and biopharmaceuticals for applications involving humans [Baldi et al, 2007, Daniell et al, 2001, Walsh, 2006, Wurm, 2004. Animal cell lines, such as Chinese hamster ovary (CHO), hybridoma, human embryo kidney (HEK) or baby hamster kidney (BHK) cells are commonly used as production cells [Baldi et al, 2007, Butler, 2005, Walsh, 2006, Wurm, 2004.…”
Section: Introductionmentioning
confidence: 99%
“…Plants are becoming a common platform for production of recombinant proteins such as industrial enzymes and pharmaceuticals (Daniell et al 2001;Kusnadi et al 1997). A production system using recombinant plants potentially offers great advantages over those based on microorganisms or animal cells when foreign gene products are produced, because it can be applied to traditional agricultural system at low cost (Twyman et al 2003).…”
Section: Introductionmentioning
confidence: 99%